Recruiting NA Depressive Symptoms

New treatment option for Depressive Symptoms

Official title Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)

ClinicalTrials.gov ID: NCT07020572

What this study is testing

What it's testing
This pilot randomized controlled trial will examine the feasibility, acceptability and preliminary efficacy of an adolescent depression prevention program, Brief Interpersonal Psychotherapy-Adolescent Skills Training (B-IPT-AST), in primary care.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 13 to 17

You may be able to join if

  • For Adolescent Participants
  • Adolescents ages 13 to 17 years.
  • Adolescents must be English-speaking.
  • Legal guardian permission (informed consent) and child consent/assent.
  • A score of 5-10 on the Patient Health Questionnaire 9-Item: Modified for Teens (PHQ-9-M) at the primary care well-visit.

You likely can't join if

  • Exclusion criteria will be determined based on electronic health record (EHR) review, eligibility screening questions, the baseline evaluation, and...
  • Suicidal ideation or behaviors reported on the PHQ-9-M at their well-visit (score of 1 or higher on item 9 "In the past week, have you had thoughts...
  • Major medical illness, significant behavioral problems or intellectual or developmental disabilities that may interfere with the completion of all...
  • Youth may be excluded on a case-by-case basis if the EHR review, eligibility screener, baseline evaluation, or other interactions with the family...
See the full eligibility criteria
Who can join
  • For Adolescent Participants
  • Adolescents ages 13 to 17 years.
  • Adolescents must be English-speaking.
  • Legal guardian permission (informed consent) and child consent/assent.
  • A score of 5-10 on the Patient Health Questionnaire 9-Item: Modified for Teens (PHQ-9-M) at the primary care well-visit.
  • Access to a phone, computer, or other electronic device that could be used for study activities For Legal guardian Participants
  • Legal guardian of an adolescents ages 13 to 17 years who scored 5-10 on the PHQ-9-M at the primary care well-visit.
  • Consent to participate.
  • English-speaking.
  • Access to a phone, computer, and/or tablet to complete remote evaluations.
What rules you out
  • Exclusion criteria will be determined based on electronic health record (EHR) review, eligibility screening questions, the baseline evaluation, and any other interactions with the family.
  • Suicidal ideation or behaviors reported on the PHQ-9-M at their well-visit (score of 1 or higher on item 9 "In the past week, have you had thoughts that you would be better off dead, or of hurting yourself in some way?"...
  • Major medical illness, significant behavioral problems or intellectual or developmental disabilities that may interfere with the completion of all study procedures.
  • Youth may be excluded on a case-by-case basis if the EHR review, eligibility screener, baseline evaluation, or other interactions with the family suggests that the group program would not be appropriate.

The study team makes the final eligibility decision.

Where it's taking place

  • Philadelphia, Pennsylvania, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 13 years to 17 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.